Search results
Results from the WOW.Com Content Network
In the quarter ended June 30, Edwards' revenue rose 11% to $1.53 billion, above estimates of $1.50 billion. Excluding items, it made a profit of 66 cents per share, compared with estimates of 65 ...
Edwards Lifesciences (EW) closed at $111.61 in the latest trading session, marking a -0.68% move from the prior day. ... News. 24/7 help. For premium support please call: 800-290-4726 more ways to ...
Edwards Lifesciences (EW) closed the most recent trading day at $105.33, moving -0.58% from the previous trading session. Edwards Lifesciences (EW) Stock Moves -0.58%: What You Should Know Skip to ...
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [ 4 ]
On Wednesday, during its annual investor conference, Edwards Lifesciences Corporation (NYSE:EW) detailed its strategy for sustained long-term growth and innovations in structural heart therapies.
The stock of Edwards Lifesciences (NYSE:EW, 30-year Financials) gives every indication of being modestly overvalued, according to GuruFocus Value calculation.
You should check out Brown Advisory’s top 5 stock picks for […] The Large-Cap Growth Fund posted a return of 27.86% for the quarter, outperforming its benchmark, the Russell 1000 Growth Index ...
Investor confidence is high in Edwards Lifesciences (EW) stock, courtesy of solid prospects.